Healthcare utilization and costs for patients with Parkinson’s disease in Taiwan

BMC Neurology

Table 2 Mean predicted values¹ of medical care utilization and costs among patients with PD and non-PD^a

Variables	Beta	SE	Standardized beta	PD patients (N = 50,290)		Non-PD subjects (N = 201,153)		P-value¹
Variables	Beta	SE	Standardized beta	Predicted mean	SE	Predicted mean	SE	P-value¹
Frequency of Care
Outpatient Care^b	19.11	0.72	0.05	167.41	0.65	148.30	0.32	< .0001
Inpatient Care^c	0.58	0.02	0.06	3.17	0.02	2.59	0.01	< .0001
Accidents (in- or outpatient)	0.89	0.03	0.05	4.62	0.03	3.73	0.01	< .0001
Hospitalization Days^d	12.95	0.51	0.05	43.81	0.45	30.86	0.23	< .0001
Cost of Care^e (NT$/10³)
Outpatient Care^b	85.58	2.20	0.08	345.37	1.96	259.79	0.98	< .0001
Inpatient Care^c	60.29	2.42	0.05	264.94	2.16	204.65	1.08	< .0001
Accidents (in- or outpatient)	4.33	0.15	0.06	20.77	0.14	16.44	0.07	< .0001
Total Medical Costs	150.21	3.60	0.08	631.08	3.21	480.88	1.60	< .0001
Drug cost (NT$/10³)
Outpatient Care^b	74.68	1.15	0.13	185.46	1.03	110.78	0.51	< .0001
Inpatient Care^c	7.66	0.40	0.04	35.64	0.36	27.98	0.18	< .0001
Accidents (in- or outpatient)	0.36	0.02	0.03	1.72	0.02	1.36	0.01	< .0001
Total Drug Costs	82.70	1.28	0.13	222.81	1.14	140.12	0.57	< .0001

Betas represent the difference in costs between PD and non-PD subjects. Standardized betas allow to compare differences for the different costs
SE Standard error
^aThe average length of follow-up was 5.92 years for PD cases and 6.55 years for non-PD cases. The total follow-up person years was 297,711.19 for PD cases and 1,317,839.29 for non-PD cases
^bExclude accidents and emergency care/medical costs
^cExclude accidents care/medical cost
^dTotal hospitalization days including hospitalization due to accidents
^eCosts were deflated by the consumer price index (CPI) with the bas year of 2016
¹Models were adjusted for age, gender, urbanization status, insurance premium, and comorbidity

ISSN: 1471-2377